Organon is focusing on expanding the women's health lineup
By | translator Choi HeeYoung
22.03.02 12:00:11
°¡³ª´Ù¶ó
0
At the first meeting since its launch, women's health was presented as a vision
New products will be introduced
The demand for unmet diseases related to women's entire life cycle was relatively high.
Organon will focus on improving treatment accessibility so that all women can enjoy healthier daily lives." At a press conference held by Organon for the first time since its launch at The Plaza Hotel in Jung-gu, Seoul on the morning of the 2nd, CEO Kim So-eun made the remarks about the company's vision.
¡ãKim Soeun, CEO of Oganon Korea
Organon, which spun off from MSD, was officially launched in June last year. Founded in the Netherlands in 1923, Organon was merged with Organon and absorbed into MSD. After about a decade, it was separated from MSD again. Organon, headquartered in New Jersey, USA, has subsidiaries and six manufacturing facili
(same@dailypharm.com)
If you want to see the full article, please JOIN US (click)